Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlookLena Horvath(Innsbruck Medical University), Andreas Pircher(Innsbruck Medical University)Molecular CancerSeptember 11, 202010.1186/s12943-020-01260-zCited by 300SaveCiteExport RISWatch citationsRelated PapersComprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer|Molecular Cancer|2022|177